Radiation May Be Unnecessary for Many Breast Cancer Patients — and Plastic Surgeons Are Thrilled

A New York Times article today highlighted a study just published in the New England Journal of Medicine — and as a plastic surgeon who takes care of breast cancer patients, I am genuinely thrilled about it.

The trial enrolled women who had:

• Mastectomy
• Chemotherapy
• Intermediate-risk breast cancers

This is exactly the group that would traditionally be recommended to receive post-mastectomy radiation therapy. In the study, these women were randomized into two groups:

1. Radiation
2. No radiation

The median follow-up was nearly 10 years — meaningful long-term data, not a snapshot.

At a decade out, the comparison between the two groups was striking:

• No difference in mortality
• No difference in cancer spread (metastasis)
• A small difference in recurrence, but the overall recurrence rate in the entire study was very low

In other words: for this intermediate-risk group, getting radiation didn't meaningfully change the outcome that matters most — survival.

In the United States, the majority of mastectomy patients go on to have an implant-based breast reconstruction. And radiation — while a powerful cancer treatment — is extremely challenging for breast implants.

Even when we do this all the time, radiation adds:

• Increased risk of capsular contracture — the tissue becomes tight and fibrotic
• Higher overall complication rates
• Worse fat grafting take when we try to refine the reconstruction afterward
• More difficulty achieving symmetry between the two sides
• Poorer cosmetic outcomes overall

So any time radiation can be safely avoided without compromising cancer care, it's a huge win for the patient's long-term reconstruction. If you've already had radiation, here's how revision after radiation works.

What's also exciting is what may be coming around the bend.

For chemotherapy, we already have sophisticated tools like:

• Oncotype DX
• MammaPrint

These tests look at the genetics of your individual tumor and give us a personalized estimate of your recurrence risk — which helps us decide whether or not you actually need chemo. It's a huge leap beyond the old one-size-fits-all approach.

Similar testing is on the horizon for radiation recommendations — the ability to look at your specific tumor biology and get a more personalized answer on whether radiation will actually help you.

If you've seen my previous video on it, the test gaining traction in my area for post-mastectomy radiation decisions is called AidaBreast. It's now available in my area.

The goal of all of this is simple: use these therapies in the patients who will actually benefit — and spare the patients who won't.

That means:

• Fewer patients radiated unnecessarily
• Fewer long-term reconstruction complications from radiation
• Better quality of life after cancer
• Same (or better) cancer outcomes, thanks to more precise decision-making

For intermediate-risk breast cancer patients who've had a mastectomy and chemotherapy, a major new trial suggests that radiation may not improve long-term outcomes — and tools like AidaBreast and MammaPrint-style radiation tests are moving us toward personalized recommendations.

If you're a breast cancer patient navigating decisions about radiation, bring this up with your oncology team. The landscape is changing fast, and you may have more options — and more data behind those options — than the standard recommendation suggests.

Your local plastic surgeon, I can promise you, is very happy about it.